Dr. Kyu Rhee remembers the exact moment he realized the power of bridging medicine and science—standing at a patient’s bedside with a stethoscope in one hand and a research hypothesis in mind. That dual identity, shared by physician-scientists across generations, has led to breakthroughs like statins, mRNA vaccines, and personalized cancer therapies. Yet today, that vital role is vanishing: over the past four decades, the number of physician-scientists in the U.S. has plummeted by nearly 70%, threatening the very engine of medical innovation.
This decline isn’t accidental. A new paper in JCI Insight, co-authored by Rhee and a consortium of 20 leading institutions—including Weill Cornell Medicine, Vanderbilt University Medical Center, the American Society for Clinical Investigation, and the Burroughs Wellcome Fund—reveals a systemic failure to support these hybrid professionals. Unlike pure clinicians or lab-based researchers, physician-scientists split their time between treating patients and conducting research inspired by those same patients. But without formal career pathways, dedicated funding, or institutional recognition, many are forced to abandon research or leave academia altogether.
The consequences ripple through every hospital and lab. When physician-scientists disappear, so do the real-time insights that turn clinical observations into cures. The paper diagnoses the problem clearly: a lack of infrastructure, competing financial pressures from clinical duties and grant cycles, and no standardized model for promotion or support. But it also offers a cure. The authors propose a concrete institutional framework built on three pillars—academic, financial, and organizational—that academic medical centers can adopt and adapt to stabilize this endangered workforce.
At Weill Cornell Medicine, the response is already underway. Under its strategic CARE plan, the institution has launched a three-year pilot program to test this very model, starting with junior faculty who’ve completed training and launched independent research programs. These early-career physician-scientists will receive structured mentorship, protected research time, and dedicated funding—resources designed to honor the substantial investment already made in their dual training. The goal is not just retention, but transformation: creating a sustainable career path that others can replicate nationwide.
"The growing deficit of physician-scientists is both a crisis and a unique opportunity," said Rhee, who serves as vice chair of research at Weill Cornell and treats patients at NewYork-Presbyterian/Weill Cornell Medical Center. "We can rebuild a system that doesn’t force them to choose between healing patients and discovering new treatments." If successful, this model could reignite a pipeline that doesn’t just advance science—but redefines what’s possible in medicine.